Skip to main content
Login
Contact
Subscribe
ShopMarshallCountyOnline
Search form
Search
The Pilot News
Home
Forms
News
The Leader of Starke County
Culver Citizen
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Entertainment
Calendar
Friends To Follow
Special Sections
Talking About...
Photos
Videos
Games
Local Guide
Local Ads
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Aytu Bioscience Inc
(NQ:
AYTU
)
1.170
USD
+0.070 (+6.36%)
Official Closing Price
/ Updated:
4:52 PM EST, Feb 22, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
289,195
Open
1.100
Bid (Size)
1.120 (1)
Ask (Size)
1.210 (1)
Prev. Close
1.100
Today's Range
1.100 - 1.230
52wk Range
0.2330 - 6.960
Shares Outstanding
35,883,069
Dividend Yield
N/A
Performance
YTD
+46.25%
+46.25%
1 Month
+9.35%
+9.35%
3 Month
+34.48%
+34.48%
6 Month
-73.71%
-73.71%
1 Year
+0.86%
+0.86%
Top News
More News
Aytu BioScience Reports 71% Revenue Growth in Q2 FY19
February 07, 2019
from
ACCESSWIRE
Aytu BioScience to Report Fiscal Second Quarter 2019 Results and Business Update
January 31, 2019
from
ACCESSWIRE
More News
Read More
Aytu BioScience Announces U.S. Field Sales Launch of Tuzistra(R) XR
January 15, 2019
from
ACCESSWIRE
Aytu BioScience Provides Natesto(R) Commercial Update for the Quarter Ending December 31, 2018, Reports 27% Prescription Growth and Expansion of Natesto(R) Direct Program
January 10, 2019
from
ACCESSWIRE
Aytu BioScience Announces Commercial Availability of Tuzistra(R) XR (codeine polistirex and chlorpheniramine polistirex) oral suspension
December 06, 2018
from
ACCESSWIRE
Aytu BioScience Provides Webcast Information for 2018 LD Micro Conference Presentation
December 04, 2018
from
ACCESSWIRE
Aytu BioScience Announces Appointment of Two New Directors, Steven Boyd and Ketan Mehta
December 03, 2018
from
ACCESSWIRE
Aytu BioScience (AYTU) Should Be A $10 Stock Today, Analysts Agree
February 20, 2019
from
Press Release Jet
Aytu BioScience Announces Closing of $5M Investment from Armistice Capital
November 30, 2018
from
ACCESSWIRE
Aytu BioScience to Present at 11th Annual LD Micro Main Event Investor Conference on December 5, 2018
November 27, 2018
from
ACCESSWIRE
Investor Expectations to Drive Momentum within ANGI Homeservices, Aytu Bioscience, IRIDEX, Cellular Biomedicine Group, CounterPath, and EXFO — Discovering Underlying Factors of Influence
November 16, 2018
from
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.